Hikari Power Ltd - Q3 2018 holdings

$984 Million is the total value of Hikari Power Ltd's 127 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 35.0% .

 Value Shares↓ Weighting
BRKA BuyBERKSHIRE HATHAWAY INC CLASS Acl a$232,000,000
+15.2%
725
+1.5%
23.59%
+6.4%
JNJ BuyJOHNSON & JOHNSON$37,515,000
+25.2%
271,510
+10.0%
3.81%
+15.6%
MMM Buy3M CO$31,535,000
+12.7%
149,660
+5.2%
3.21%
+4.1%
AGN BuyALLERGAN PLCsponsored adr$29,254,000
+50.3%
153,580
+31.6%
2.97%
+38.8%
NSRGY BuyNESTLE SAsponsored adr$18,428,000
+24.5%
221,490
+15.9%
1.87%
+15.0%
KHC BuyTHE KRAFT HEINZ COMPANY$14,005,000
+9.7%
254,130
+25.0%
1.42%
+1.3%
GIS BuyGENERAL MILLS,INC$11,614,000
+53.5%
270,600
+58.2%
1.18%
+41.8%
CL BuyCOLGATE-PALMOLIVE COMPANY$9,011,000
+20.2%
134,590
+16.3%
0.92%
+11.0%
BUD BuyANHEUSER-BUSCH INBEV NVsponsored adr$8,490,000
+22.1%
96,950
+40.5%
0.86%
+12.8%
USB BuyUS BANCORP$6,057,000
+7.3%
114,700
+1.6%
0.62%
-1.0%
GE BuyGENERAL ELECTRIC COMPANY$5,889,000
-14.5%
521,600
+3.0%
0.60%
-21.1%
VDC BuyVANGUARD CONSUMER STAPLES ETFetf$5,689,000
+60.4%
40,600
+53.7%
0.58%
+48.2%
SGYPQ BuySYNERGY PHARMACEUTICALS INC$4,250,000
+6.2%
2,500,000
+8.7%
0.43%
-2.0%
MO BuyALTRIA GROUP INC$2,922,000
+58.3%
48,450
+49.1%
0.30%
+46.3%
AKTX BuyAKARI THERAPEUTICS PLC$2,560,000
+55.5%
1,000,000
+18.5%
0.26%
+43.6%
ASHR BuyDEUTSCHE X-TRACKERS HARVEST CSI 300 CHINA A-SHARES FUNDetf$2,446,000
+51.9%
96,500
+59.0%
0.25%
+40.7%
DVAX BuyDYNAVAX TECHNOLOGIES CORPORATION$1,931,000
-3.2%
155,755
+19.1%
0.20%
-10.5%
HDV BuyISHARES CORE HIGH DIVIDEND ETF$1,675,000
+272.2%
18,500
+249.1%
0.17%
+240.0%
VWO BuyVANGUARD FTSE EMERGING MARKETS ETF$1,402,000
+95.5%
34,200
+101.2%
0.14%
+81.0%
BK NewBANK OF NEW YORK MELLON CORP$1,290,00025,300
+100.0%
0.13%
OCUL BuyOCULAR THERAPEUTIX INC$826,000
+53.0%
120,001
+50.0%
0.08%
+42.4%
SPHS NewSOPHIRIS BIO INC$474,000170,000
+100.0%
0.05%
CBIO NewCATALYST BIOSCIENCES INC$323,00030,000
+100.0%
0.03%
CRVS NewCORVUS PHARMACEUTICALS INC$275,00032,090
+100.0%
0.03%
BRKB NewBERKSHIRE HATHAWAY INC CLASS Bcl b$214,0001,000
+100.0%
0.02%
SESN NewSESEN BIO INC$141,00065,592
+100.0%
0.01%
SBPH NewSPRING BANK PHARMACEUTICALS$137,00011,336
+100.0%
0.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Yasumitsu Shigeta #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-10-31
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARDINAL HEALTH39Q3 202340.7%
WELLS FARGO & CO NEW39Q3 202317.8%
JOHNSON & JOHNSON39Q3 202324.8%
VISA INC CLASS A39Q3 20234.1%
NOVO-NORDISK A S39Q3 20234.2%
EXXON MOBIL CORPORATION39Q3 20233.9%
NESTLE SA39Q3 20233.6%
COCA COLA CO39Q3 20236.4%
INTUITIVE SURGICAL INC39Q3 20232.2%
BECTON DICKINSON & CO39Q3 20232.8%

View Hikari Power Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-08
13F-HR2024-01-31
13F-HR2023-10-26
13F-HR2023-07-26
13F-HR2023-04-26
13F-HR2023-01-25
13F-HR2022-11-01
13F-HR/A2022-07-22
13F-HR2022-07-06
13F-HR2022-04-13

View Hikari Power Ltd's complete filings history.

Compare quarters

Export Hikari Power Ltd's holdings